Proximo™ solution addresses long-standing problem in genome assembly. San Diego, CA Seattle-based Phase Genomics has announced the general availability of Proximo™, a new service providing complete end-to-end genome assemblies to researchers around the globe. Long considered a “holy grail” in biological research, access to complete genomes eliminates a major obstacle in answering a wide range […]
Technology Platform Will Help Monsanto Analyze, Store And Mine Its Industry-Leading Broad Genomic Data Sets To Enhance Breeding And R&D Opportunities ST. LOUIS & NESS ZIONA, Israel–(BUSINESS WIRE)–Monsanto Company (NYSE: MON) and NRGene announced today that the companies have reached a non-exclusive, multi-year global licensing agreement on NRGene’s genome-analysis technology to enhance Monsanto’s ability to […]
Three-Year Renewable Agreement Also Includes Non-Exclusive License to ICP in Canada New Patent Has Issued Covering ICE COLD-PCR Technology in Canada OMAHA, Neb. — Transgenomic, Inc. (TBIO) (NASDAQ: TBIO), today announced a licensing agreement with leading Canadian laboratory services provider LifeLabs, which has selected Transgenomic’s ICE COLD-PCR (ICP) technology as its mutation enrichment platform […]
Companies Complete High Quality Assembly of Nellore Cattle Genome in Conjunction with Universidade Estadual Paulista SAN DIEGO & NESS ZIONA, Israel— Illumina, Inc. (NASDAQ: ILMN), the global leader in next-generation sequencing technology, and NRGene, a globally recognized leader in genome assembly and analysis, today announced a collaboration to develop new molecular breeding tools for cattle. As a first step, the […]
Leading Provider of Cloud-based Genomics Technology Joins HCA’s Global Cancer Institute to Grow Reach in Precision Medicine for People Facing Cancer Across the US & UK Nashville, Tenn. and Cambridge, Mass. – Sarah Cannon, the Cancer Institute of Hospital Corporation of America (HCA), today announced that Genospace, LLC, a cloud-based software company focused on advancing personalized medicine, […]
Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Dr. Klaus Lun, Head of Corporate Development and a member of the Management Board of the Tecan Group since June 2013, has been appointed Head of the Life Sciences Business division. On December 14, 2016, Tecan announced that Dr. Stefan Traeger, Head of […]
– Expected Full Year 2016 Revenue Growth of 36% to 39% Year over Year – SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided preliminary operational and financial results for the year ended December 31, 2016. Financial Highlights: Total revenue for 2016 expected to be in […]
— Longer Synthetic DNA Accelerates Customer Discoveries — SAN FRANCISCO — Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis on silicon, today announced that it is now shipping genes up to 3,200 base pairs (3.2 kilobase or kB) in length to Ginkgo Bioworks under their existing supply agreement. “Twist Bioscience continues to […]
SAN DIEGO & HERCULES, Calif.– Illumina, Inc. (NASDAQ:ILMN) and Bio-Rad Laboratories, Inc. (NYSE:BIO) (NYSE:BIOb) today announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers the ability to investigate the coordinated contribution of individual cells in tissue function, disease progression, and therapeutic response. […]
Data interpretation from Watson will help users translate genomic data from Illumina TruSight® Tumor 170; offering to be available early in 2017 SAN FRANCISCO – IBM Watson Health (NYSE:IBM) and Illumina, Inc. (NASDAQ:ILMN) today announced a groundbreaking partnership to expand access to genome data interpretation by integrating Watson for Genomics into Illumina’s BaseSpace Sequence Hub and tumor sequencing […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
